Nautilus Biotechnology, Inc. (NAUT) stock
NAUTNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
$2.36+0.26 (+12.38%)
Close on Nov 17, 2026Market cap $300.60MP/E –Yield –
Nautilus Biotechnology cash
Cash and short-term investments held at the end of each period.
Nautilus Biotechnology's cash was $114.30M at Sep 30, 2026. For fiscal 2025 it was $103.40M, down 20.4% from the year before. The highest annual figure on record is $345.70M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $103.40M | -20.4% |
| FY2024 | Dec 31, 2024 | $129.90M | -25.1% |
| FY2023 | Dec 31, 2023 | $173.40M | -6.0% |
| FY2022 | Dec 31, 2022 | $184.50M | -46.6% |
| FY2021 | Dec 31, 2021 | $345.70M | +346.9% |
| FY2020 | Dec 31, 2020 | $77.35M | +12900.7% |
| FY2019 | Dec 31, 2019 | $595.00K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $114.30M | -13.0% |
| Q2 FY2026 | Jun 30, 2026 | $84.00M | -43.2% |
| Q1 FY2026 | Mar 31, 2026 | $95.90M | -30.9% |
| Q4 FY2025 | Dec 31, 2025 | $103.40M | -20.4% |
| Q3 FY2025 | Sep 30, 2025 | $131.40M | -6.5% |
| Q2 FY2025 | Jun 30, 2025 | $147.90M | -11.6% |
| Q1 FY2025 | Mar 31, 2025 | $138.80M | -23.5% |
| Q4 FY2024 | Dec 31, 2024 | $129.90M | -25.1% |
| Q3 FY2024 | Sep 30, 2024 | $140.60M | -23.3% |
| Q2 FY2024 | Jun 30, 2024 | $167.40M | +2.5% |
| Q1 FY2024 | Mar 31, 2024 | $181.40M | +8.4% |
| Q4 FY2023 | Dec 31, 2023 | $173.40M | -6.0% |
| Q3 FY2023 | Sep 30, 2023 | $183.30M | -29.0% |
| Q2 FY2023 | Jun 30, 2023 | $163.30M | -45.4% |
| Q1 FY2023 | Mar 31, 2023 | $167.30M | -48.4% |
| Q4 FY2022 | Dec 31, 2022 | $184.50M | -46.6% |
| Q3 FY2022 | Sep 30, 2022 | $258.00M | -25.7% |
| Q2 FY2022 | Jun 30, 2022 | $299.30M | -19.8% |
| Q1 FY2022 | Mar 31, 2022 | $324.10M | +518.3% |
| Q4 FY2021 | Dec 31, 2021 | $345.70M | +346.9% |
| Q3 FY2021 | Sep 30, 2021 | $347.30M | +2523.1% |
| Q2 FY2021 | Jun 30, 2021 | $373.10M | +1035.0% |
| Q1 FY2021 | Mar 31, 2021 | $52.42M | – |
| Q4 FY2020 | Dec 31, 2020 | $77.35M | +12900.7% |
| Q3 FY2020 | Sep 30, 2020 | $13.24M | – |
| Q2 FY2020 | Jun 30, 2020 | $32.87M | – |
| Q1 FY2020 | Mar 26, 2020 | $0 | – |
| Q4 FY2019 | Dec 31, 2019 | $595.00K | – |
See a number that looks wrong?